IMMATICS BIOTECHNOLOGIES GMBH
IMTXW -0.31
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 30.4M |
| Cost of Revenue | 32.1M |
| Gross Profit | -1.7M |
| Operating Expense | 41.0M |
| Operating I/L | -13.6M |
| Other Income/Expense | 11.8M |
| Interest Income | 6.3M |
| Pretax | -1.7M |
| Income Tax Expense | 1.3M |
| Net Income/Loss | -3.1M |
immatics biotechnologies GmbH
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
